Harri M. Itkonen

Castration‐resistant prostate cancer cells are addicted to the high activity of cyclin‐dependent kinase 2

Abstract Background Cyclin-dependent kinases drive the progression through the cell cycle and thereby form classical targets for cancer therapy. In prostate cancer (PC), the first line of therapy typically targets androgen receptor (AR), but it frequently leads to development of...